Helsinn Birex Pharmaceuticals Ltd.

Helsinn Birex Pharmaceuticals Ltd.

The Helsinn Group

Helsinn is a privately-owned pharmaceutical group with headquarters in Lugano, Switzerland, and operating subsidiaries in Ireland, USA and China. Founded in 1976, the company has become known worldwide for its unique business model focused on the licensing of innovative pharmaceuticals, medical devices and nutritional supplement products in therapeutic niche areas. The Group in-licenses early to late stage new chemical entities, completes their development from the performance of pre-clinical/clinical studies and Chemistry, Manufacturing and Control (CMC), development to the filing for and attainment of their market approval worldwide. Helsinn’s products are out-licensed to its network of local marketing and commercial partners worldwide, selected for their deep in-market knowledge and know-how, and assisted and supported with a full range of product and scientific management services, including commercial, regulatory, financial, legal and medical marketing advice. The active pharmaceutical ingredients and the finished dosage forms are manufactured at Helsinn’s cGMP facilities in Switzerland and Ireland, and supplied worldwide to its customers.

Today Helsinn is committed to advancing quality patient care through the development and commercialization of cancer supportive care treatments to benefit both patients and caregivers. Helsinn focuses R&D investments and resources on enhancing cancer supportive care, a still underserved yet important therapeutic area.

A modern Group focused on growth and development but also tied to tradition and on the values of a family business: in Helsinn more than 500 employees work not only for the health of the patient, but overall for the quality of life of the person.

Helsinn Birex Pharmaceuticals Ltd, Dublin

Ireland is a global center for pharmaceuticals manufacturing and supply for the top pharmaceutical companies worldwide with an excellent reputation for GMP compliance.

Since 1997 Helsinn Birex Pharmaceuticals has operated from a new state of art finished dosage facility in Damastown, Dublin, Ireland. From here Helsinn supplies its partners globally with ready to sell products on an exclusive basis, which are manufactured on site and/or using a netwowrk of high quality external manufacturing partners (CMO’s) located around the world.

In 2009 the Helsinn Group invested over EUR 13 million, with the support of the Irish Development Authority (IDA), to build a Centre-of-Excellence for oral solid dosage forms and Stability centre focused on developing the group pipeline of new solid dose products.

In 2011, further investments were made to increase the analytical testing capacity on the site. Helsinn has invested more than CHF50 million in Dublin and in dedicated capacity at the sites of its strategic contract manufacturing partners to guarantee all elements of the supply chain for development and commercial products.


  • Building area 8,000 m2 on a Site area of 27.100m2
  • Oral solid dosage forms, topical forms and packaging of sterile products
  • Worldwide logistic platform
  • Solid dose development and clinical supply
  • Stability center
  • Employment ca 180 (2014)

Helsinn Birex offers interesting and challenging careers in a team based workplace with modern facilities and opportunities for advancement. 

Overall rating
Based on 4 reviews
  • Office & Transport links
  • Culture & people
  • Training & development
  • Work/Life balance
  • Career progression

Read reviews


Email me jobs from Helsinn Birex Pharmaceuticals Ltd.

Please enter your email address

Helsinn Birex Pharmaceuticals Ltd. Jobs

Analytical Development Chemist

  • Not disclosed
  • Updated 23/03/2017
  • Dublin

The primary purpose of the Analytical Development Chemist is to perform analytical method development and validation of same for the Helsinn Group's pipeline of Cancer Care products currently under development.

QC Stability Team Leader

  • Not disclosed
  • Updated 22/03/2017
  • Dublin

Helsinn Birex seeks an experienced Stability Team Leader within Quality Control

Maintenance Technician (Pharmaceutical - Process and Packaging)

  • Not disclosed
  • Updated 21/03/2017
  • Dublin

The primary purpose of the Maintenance Technician is to support the Maintenance Supervisor by carrying out maintenance duties and engineering projects associated primarily with Oral Solid Dosage Processing and Packaging equipment.

Qualified Person (part-time)

  • Not disclosed
  • Updated 20/03/2017
  • Dublin

A Qualified Person is required at Helsinn Birex Pharma on a part-time basis.

Helsinn Birex Pharmaceuticals reviews

My Best Job Ever

Anonymous in Dublin, Ireland
former employee in 2015

The Best Bits

I loved working here as the people and the lab were great. Everyone was friendly and willing to help and the managers listened to what you had to say. Even when something went wrong, there was never just blaming you for the problem, everyone tried to help and never made you feel worse about it.

Things to improve

I think more movement of analysts between teams every so often would help them gain skills and improve morale a bit as doing the same thing for what feels like ages can be quite boring.


Please describe the problem with this review.

A great place to work. Lots of development opportunities

Anonymous in Dublin, Ireland
former employee in 2016

The Best Bits

Great people, great learning opportunities

Things to improve

More integration across the group


Please describe the problem with this review.

Excellent Company

Anonymous in Mulhuddart, Ireland
current employee in _ 2016

The Best Bits

Pleasant working environment, opportunities to take on extra project work, excellent management.

Things to improve

Introduce flexi time to include time in lieu worked up


Please describe the problem with this review.


We use cookies to customise our website for you, giving you the best possible user experience. If you continue without changing your settings, we’ll assume that you are happy to receive this personalisation. Find out more about our cookie policy

Accept & Close